Agios Pharmaceuticals, Inc.

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Director or officer change; Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release) Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Regulation FD disclosure Aug 4, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Director or officer change Jul 8, 2025 8-K Director or officer change; Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 13, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K Director or officer change Feb 13, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure Jan 6, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Shareholder vote results Jun 20, 2024 8-K Entered a material agreement; Other events May 28, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 15, 2024 8-K Results of operations (earnings release) Feb 15, 2024 8-K Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023 8-K Director or officer change; Shareholder vote results Jun 14, 2023 8-K Director or officer change May 25, 2023 10-Q Quarter ended 2023-03-31 May 4, 2023